Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Organizations Community Improvement & Capacity Building Bulk Pharmaceuticals Task Force

Bulk Pharmaceuticals Task Force

Fiscal year ending 2023. Filed on May 8, 2024.

5936 Boone Avenue
Baton Rouge, Louisiana 70808

Bulk Pharmaceuticals Task Force (EIN: 84-5175638) has filed an IRS Form 990 since fiscal year 2021. In its fiscal year 2023 IRS Form 990 filing, Bulk Pharmaceuticals Task Force, a 501(c)(6) business league, reported compensation for 3 employees. Among the employees shown here, the average compensation is $0.

Revenue, expenses, and employee compensation

Revenue

$82,992

Expenses

$71,542

Employee compensation

$0
Revenue, expenses, and employee compensation over time

Reported Compensated Employees

Brant Zell
Chair
$0
Deborah Attwood
Vice Chair
$0
Jeff Robinson
Treasurer
$0

Benchmark Employee Compensation

Mission Statement

Primary Exempt Purpose The Task Force is formed as a business league, within the meaning of section 501(c)(6) of the Internal Revenue Code, to advocate for the manufacturers of active pharmaceutical ingredients, intermediates, and excipients.

Revisions to this organization profile

April 29, 2025:
2024 Bulk Pharmaceuticals Task Force 990 filed
May 8, 2024:
2023 Bulk Pharmaceuticals Task Force 990 filed
August 7, 2023:
2022 Bulk Pharmaceuticals Task Force 990 filed

Get an email when new compensation information is released for Bulk Pharmaceuticals Task Force

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →